Targeting Tumor Microenvironment for Cancer Therapy
Open accessThe DOI matches its Crossref record; 209 of the 212 references it cites were found in a registry or an index.
Abstract
Cancer development is highly associated to the physiological state of the tumor microenvironment (TME). Despite the existing heterogeneity of tumors from the same or from different anatomical locations, common features can be found in the TME maturation of epithelial-derived tumors. Genetic alterations in tumor cells result in hyperplasia, uncontrolled growth, resistance to apoptosis, and metabolic shift towards anaerobic glycolysis (Warburg effect). These events create hypoxia, oxidative stress and acidosis within the TME triggering an adjustment of the extracellular matrix (ECM), a response from neighbor stromal cells (e.g., fibroblasts) and immune cells (lymphocytes and macrophages), inducing angiogenesis and, ultimately, resulting in metastasis. Exosomes secreted by TME cells are central players in all these events. The TME profile is preponderant on prognosis and impacts efficacy of anti-cancer therapies. Hence, a big effort has been made to develop new therapeutic strategies towards a more efficient targeting of TME. These efforts focus on: (i) therapeutic strategies targeting TME components, extending from conventional therapeutics, to combined therapies and nanomedicines; and (ii) the development of models that accurately resemble the TME for bench investigations, including tumor-tissue explants, “tumor on a chip” or multicellular tumor-spheroids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Main properties of in vitro 2D and 3D culture systems [187,188]. CAF, Cancer-associated fibroblast; ECM, Extracellular matrix.](https://figures.cochat.ai/paper-figures/5beab1962bf5470fbdf9b87661e2bff6/targeting-tumor-microenvironment-for-cancer-therapy-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dense ECM, abnormal vasculature, and an acidified environment all contribute to decreased drug penetration [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to the microenvironment of healthy tissue, the TME has augmented deposition of proteins such as collagen and fibronectin, high cytokine levels, increased proportion of fibroblasts and immune cells, and is immunosuppressive [82,83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“agents that degrade and/or deconstruct the ECM should be used cautiously, as they may lead to the release of factors that promote tumor progression and induce metastasis [83].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 1×
“Concerning the therapeutic outcome of such drugs, although they showed to improve patient survival, it has not been as great as expected, mostly related to the fact that patients stop responding or do not respond at all to these therapies, or even due to the side effects, for instance, the increased risk of arterial t…”
BackgroundElements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352 · cited 1×
“While some tumors present few signals of inflammation, others show a high number of immune cells either at the periphery or infiltrated within the tumor [70,71].”
BackgroundMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 3×
“Epithelial tumors display common features that allow for the setting of hallmarks that define cancer progression [7,8].”
BackgroundTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“For this reason, tumors are frequently regarded as “wounds that never heal” [7,92].”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Research works printed but not linked: 1
- Larson B. 3D cell culture: A review of current techniques BioTek 2015 6 1 10
Cited by
Items 201–300 of 1,000
Xu, S., Wang, Q., & Ma, W. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.02.003 · Cited by 55
Shabbir, M., Atiq, A., Wang, J., Atiq, M., Saeed, N., Yıldız, İ., Yan, X., Xing, R., & Abbas, M. (2024) · Aggregate · doi:10.1002/agt2.672 · Cited by 49
In-vitro and in-vivo difference in gene delivery by lithocholic acid-polyethyleneimine conjugate
Wang, J., Meng, F., Kim, B.-K., Ke, X., & Yeo, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119296 · Cited by 50
The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy
Wo, Y. J., Gan, A. S. P., Lim, X., Tay, I. S. Y., Lim, S., Lim, J. C. T., & Yeong, J. P.-S. (2019) · Cells · doi:10.3390/cells9010026 · Cited by 53
Akhter, M. H., Beg, S., Tarique, M., Malik, A., Afaq, S., Choudhry, H., & Hosawi, S. B. I. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129777 · Cited by 51
Targeting the Tumor Microenvironment: An Unexplored Strategy for Mutant KRAS Tumors
Carvalho, P. D., Machado, A. L., Martins, F., Seruca, R., & Velho, S. (2019) · Cancers · doi:10.3390/cancers11122010 · Cited by 51
Growth hormone in the tumor microenvironment
Chesnokova, V., & Melmed, S. K. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000186 · Cited by 52
Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics
Ferreira, D., Fontinha, D., Martins, C., Pires, D., Fernandes, A. R., & Baptista, P. V. (2020) · Molecules · doi:10.3390/molecules25153489 · Cited by 62
Self-citationRole of tumour-derived exosomes in metastasis
Bai, S., Wei, Y., Liu, R., Xu, R., Li, X., & Du, J. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112657 · Cited by 56
Valencia, J., Fernández-Sevilla, L. M., Fraile‐Ramos, A., Sacedón, R., Jiménez, E., Vicente, Á., & Varas, A. (2019) · Cells · doi:10.3390/cells8070722 · Cited by 51
Anti-Tumor Effects of Chinese Medicine Compounds by Regulating Immune Cells in Microenvironment
Chen, F., Li, J., Wang, H., & Ba, Q. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.746917 · Cited by 51
Mukashyaka, P., Kumar, P., Mellert, D. J., Nicholas, S., Noorbakhsh, J., Brugiolo, M., Courtois, E. T., Anczuków, O., Liu, E. T., & Chuang, J. H. (2023) · Nature Communications · doi:10.1038/s41467-023-44162-6 · Cited by 55
The tumor microenvironment: a key player in multidrug resistance in cancer
Meng, L., Zheng, Y., Liu, H., & Fan, D. (2024) · ONCOLOGIE · doi:10.1515/oncologie-2023-0459 · Cited by 56
Adjuvant Novel Nanocarrier-Based Targeted Therapy for Lung Cancer
Sarma, K., Akhter, M. H., Ahmad, I. S., Afzal, O., Altamimi, A. S. A., Alossaimi, M. A., Jaremko, M., Emwas, A.-H. M., & Gautam, P. (2024) · Molecules · doi:10.3390/molecules29051076 · Cited by 48
Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance
Dong, D., Xue, Y., Xu, J., Yu, N. H., Liu, Z., & Sun, Y. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2024.101125 · Cited by 52
Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation
Bishoyi, A. K., Nouri, S., Hussen, A., Bayani, A., Khaksari, M. N., & Samarkhazan, H. S. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01686-z · Cited by 51
Xu, H., Li, D., Ma, J., Zhao, Y., Xu, L., Tian, R., Liu, Y., Sun, L., & Su, J. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0211 · Cited by 50
Qiu, J., Sun, S.-G., Tang, X., Lin, Y., & Hua, K. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01745-1 · Cited by 53
Khot, V. M., Salunkhe, A. B., Pricl, S., Bauer, J., Thorat, N. D., & Townley, H. E. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.12.016 · Cited by 53
van der Heide, C. D., & Dalm, S. U. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05870-1 · Cited by 52
Kaemmerer, E., Loessner, D., & Avery, V. M. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.11.030 · Cited by 56
Tajaldini, M., Saeedi, M., Amiriani, T., Amiriani, A., Sedighi, S., Zadeh, F. M., Dehghan, M. H., Jahanshahi, M., Zanjan, M. G., Khalili, P., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175087 · Cited by 51
Role of miRNA-19a in Cancer Diagnosis and Poor Prognosis
Ardizzone, A., Calabrese, G., Campolo, M., Filippone, A., Giuffrida, D., Esposito, F., Colarossi, C., Cuzzocrea, S., Esposito, E., & Paterniti, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094697 · Cited by 48
Engineering Approaches for Breast Cancer Diagnosis: A Review
Kamal, A. M., Sakorikar, T., Pal, U. M., & Pandya, H. J. (2022) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2022.3181700 · Cited by 48
Zhang, P., Li, W., Liu, C., Qin, F., Lu, Y., Qin, M., & Hou, Y. (2023) · Exploration · doi:10.1002/exp.20230070 · Cited by 57
Ming‐Kun, C., Zi‐Xian, C., Mao‐Ping, C., Chen, H., Zhuang‐Fei, C., & Shan-chao, Z. (2023) · 癌症:英文版 · doi:10.1002/cac2.12518 · Cited by 49
Williams, C. H., Neitzel, L. R., Cornell, J. L., Rea, S., Mills, I., Silver-Isenstadt, M., Ahmad, J. D., Birukov, K. G., Birukova, A. A., Brem, H., et al. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00468-1 · Cited by 53
Borzęcka, W., Domiński, A., & Kowalczuk, M. M. (2021) · Nanomaterials · doi:10.3390/nano11092426 · Cited by 53
Notch Signaling in Breast Tumor Microenvironment as Mediator of Drug Resistance
Chimento, A., D’Amico, M., Pezzi, V., & Amicis, F. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116296 · Cited by 49
In Vitro and In Vivo Biological Activities of Dipicolinate Oxovanadium(IV) Complexes
Choroba, K., Filipe, B., Świtlicka, A., Penkala, M., Machura, B., Bieńko, A., Cordeiro, S. Z., Baptista, P. V., & Fernandes, A. R. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00255 · Cited by 46
Self-citationWang, Z., Song, K., Zhao, W., & Zhao, Z.-M. (2020) · Bioengineered · doi:10.1080/21655979.2020.1771068 · Cited by 54
Domiński, A., Krawczyk, M., Konieczny, T., Kasprów, M., Foryś, A., Pastuch-Gawołek, G., & Kurcok, P. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.07.019 · Cited by 46
Babikr, F., Wan, J., Xu, A., Wu, Z., Ahmed, S., Freywald, A., Chibbar, R., Wu, Y., Moser, M., Groot, G., et al. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00796-4 · Cited by 49
Oncogenic role and potential regulatory mechanism of topoisomerase IIα in a pan-cancer analysis
Wang, X., Wang, J., Lyu, L., Gao, X., Cai, Y., & Tang, B. (2022) · Scientific Reports · doi:10.1038/s41598-022-15205-7 · Cited by 54
Amini, P., Moazamiyanfar, R., Dakkali, M. S., Khani, A., Jafarzadeh, E., Moloudi, K., Khodamoradi, E., Johari, R., Taeb, S., & Najafi, M. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666221014152759 · Cited by 50
Hsu, T.-N., Huang, C.-M., Huang, C.-S., Huang, M.-S., Yeh, C., Chao, T.-Y., & Bamodu, O. A. (2019) · Cancers · doi:10.3390/cancers11121883 · Cited by 46
Evaluation of Intra-Tumoral Vascularization in Hepatocellular Carcinomas
Zhang, Q., Wu, J., Bai, X., & Liang, T. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.584250 · Cited by 47
Hydrogels to engineer tumor microenvironments in vitro
Fernando, K., Kwang, L. G., Lim, J. T. C., & Fong, E. L. S. (2021) · Biomaterials Science · doi:10.1039/d0bm01943g · Cited by 47
Yan, T., Chen, X., Zhan, H., Yao, P., Wang, N., He, Y., Zhang, C. L., Wang, K., Hu, H., Li, J., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03747-z · Cited by 44
RUNX2 promotes malignant progression in gastric cancer by regulating COL1A1
Li, Y., Sun, R., Zhao, X., & Sun, B. (2021) · Cancer Biomarkers · doi:10.3233/cbm-200472 · Cited by 44
Targeting cancer cachexia: Molecular mechanisms and clinical study
Wang, Y., An, Z.-Y., Lin, D., & Jin, W. (2022) · MedComm · doi:10.1002/mco2.164 · Cited by 50
Liu, H., Gonzalez, D. D., Viswanath, D. I., Pol, R. V., Saunders, S. Z., Trani, N. D., Xu, Y., Zheng, J., Chen, S., Chua, C. Y. X., et al. (2023) · Advanced Science · doi:10.1002/advs.202206873 · Cited by 50
Tumor microenvironment diversity and plasticity in cancer multidrug resistance
Li, Z., & Yin, P. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188997 · Cited by 49
Davidov, V., Jensen, G. L., Mai, S., Chen, S., & Pan, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01842 · Cited by 47
Autophagy-mediating microRNAs in cancer chemoresistance
Jing, Y., Liang, W., Liu, J., Zhang, L., Wei, J., Yang, J., Zhang, Y., & Huang, Z. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09553-1 · Cited by 42
Intelligent stimuli-responsive nano immunomodulators for cancer immunotherapy
Li, Y., Zhang, X., Liu, X., Pan, W., Li, N., & Tang, B. (2021) · Chemical Science · doi:10.1039/d0sc06557a · Cited by 45
Cancer-on-chip: a 3D model for the study of the tumor microenvironment
Cauli, E., Polidoro, M. A., Marzorati, S., Bernardi, C., Rasponi, M., & Lleò, A. (2023) · Journal of Biological Engineering · doi:10.1186/s13036-023-00372-6 · Cited by 52
A review concerning the breast cancer-related tumour microenvironment
Rodríguez-Bejarano, O. H., Parra-López, C., & Patarroyo, M. A. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104389 · Cited by 56
Mesoporous silica nanoparticle: Heralding a brighter future in cancer nanomedicine
Abbasi, M., Ghoran, S. H., Niakan, M. H., Jamali, K., Moeini, Z., Jangjou, A., Izadpanah, P., & Amani, A. M. (2021) · Microporous and Mesoporous Materials · doi:10.1016/j.micromeso.2021.110967 · Cited by 43
Engineering Next-Generation CAR-T Cells: Overcoming Tumor Hypoxia and Metabolism
Gao, T. A., & Chen, Y. Y. (2022) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-092120-092914 · Cited by 44
Ammons, D. T., Hopkins, L. S., Cronise, K. E., Kurihara, J. N., Regan, D. P., & DOW, S. W. (2024) · Communications Biology · doi:10.1038/s42003-024-06182-w · Cited by 44
Exosomal Noncoding RNAs and Tumor Drug Resistance
Guo, C., Liu, J., Zhou, Q., Song, J., Zhang, Z., Li, Z., Wang, G., Yuan, W., & Sun, Z. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0032 · Cited by 45
Mechanism of tumour microenvironment in the progression and development of oral cancer
Mughees, M., Sengupta, A., Khowal, S., & Wajid, S. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06054-6 · Cited by 48
Khesht, A. M. S., Karpisheh, V., Gilan, P. S., Melnikova, L. A., Zekiy, A. O., Mohammadi, M., Hojjat‐Farsangi, M., Zolbanin, N. M., Mahmoodpoor, A., Hassannia, H., et al. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.07.034 · Cited by 40
RetractedLi, Y., Wu, J., Qiao, L., Liu, X., Wen, J., Qi, X., Liu, J., Lian, B., Zhang, B., Sun, H., et al. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s366180 · Cited by 45
Dissecting the roles and clinical potential of YY1 in the tumor microenvironment
Li, M., Wei, J., Xue, C., Zhou, X., Chen, S., Zheng, L., Duan, Y., Deng, H., Xiong, W., Tang, F., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1122110 · Cited by 43
Herb-drug interactions in oncology: pharmacodynamic/pharmacokinetic mechanisms and risk prediction
Duan, X., Fan, X., Jiang, H., Li, J., Shen, X., Xu, Z., Zhou, Z., Xu, J., Chen, C., & Jin, H. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01156-4 · Cited by 47
Chu, Y., You, M., Zhang, J., Gao, G., Han, R., Luo, W., Liu, T., Zuo, J., & Wang, F. (2019) · Stem Cells International · doi:10.1155/2019/9037197 · Cited by 39
Dahlem, C., Siow, W. X., Lopatniuk, M., Tse, W. K. F., Kessler, S. M., Kirsch, S. H., Hoppstädter, J., Vollmar, A. M., Müller, R., Luzhetskyy, A., et al. (2020) · Cancers · doi:10.3390/cancers12051288 · Cited by 39
Past, Present, and Future of Anticancer Nanomedicine
Kim, K., & Khang, D. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s254774 · Cited by 46
Oliveira, C., Gonçalves, C. S., Martins, E. P., Neves, N. M., Reis, R. L., Costa, B. M., Silva, T. H., & Martins, A. M. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120548 · Cited by 41
Natural Killer Cells in Cancer and Cancer Immunotherapy
Raskov, H., Orhan, A., Salanti, A., Gaggar, S., & Gögenür, I. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.032 · Cited by 44
Hong, Y., & Kim, I. (2022) · BMB Reports · doi:10.5483/bmbrep.2022.55.1.075 · Cited by 39
Li, Z., Ning, F., Wang, C., Yu, H., Ma, Q., & Sun, Y. (2021) · Nanoscale · doi:10.1039/d1nr03387e · Cited by 46
Systemic Interleukins’ Profile in Early and Advanced Colorectal Cancer
Czajka‐Francuz, P., Cisoń-Jurek, S., Czajka, A., Kozaczka, M., Wojnar, J., Chudek, J. T., & Francuz, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010124 · Cited by 42
Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study
Gardini, A. C., Rimini, M., Kudo, M., Shimose, S., Tada, T., Suda, G., Goh, M. J., Jefremow, A., Scartozzi, M., Cabibbo, G., et al. (2022) · Liver Cancer · doi:10.1159/000525145 · Cited by 41
de Andrés, J. L., Ruiz-Toranzo, M., Antich, C., Chocarro‐Wrona, C., López‐Ruiz, E., Jiménez, G., & Marchal, J. A. (2023) · Biofabrication · doi:10.1088/1758-5090/ac8dc6 · Cited by 46
Hu, X., Zhu, H., Zhang, X., He, X., & Xu, X. (2021) · Cancer Medicine · doi:10.1002/cam4.4203 · Cited by 47
Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy
Li, X.-M., Zhao, Z., Xiao, Y., Xia, Q., Zhou, P., Wang, S., Wu, H., & Hu, J. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00394-2 · Cited by 41
Lu, X., Guo, H., Wei, X., Lu, D., Shu, W., Song, Y., Qiu, N., & Xu, X. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s404925 · Cited by 38
Tajaldini, M., Poorkhani, A., Amiriani, T., Amiriani, A., Javid, H., Aref, P., Ahmadi, F., Sadani, S., & Khori, V. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175991 · Cited by 40
Crosstalk Between Mesenchymal Stromal Cells and Tumor-Associated Macrophages in Gastric Cancer
Zheng, P., & Li, W. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.571516 · Cited by 44
Zarrilli, G., Businello, G., Dieci, M. V., Paccagnella, S., Carraro, V., Cappellesso, R., Miglietta, F., Griguolo, G., Guarneri, V., Mele, M. L., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218102 · Cited by 43
You, X., Wu, J., Zhao, X., Jiang, X., Tao, W., Chen, Z., Huang, C., Zheng, T., & Shen, X. (2021) · Aging · doi:10.18632/aging.203295 · Cited by 42
Guan, Z., Lan, H., Cai, X., Zhang, Y., Liang, A., & Li, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722917 · Cited by 44
Oligonucleotide conjugated antibody strategies for cyclic immunostaining
Jones, J. A., McMahon, N. P., Zheng, T., Eng, J. R., Chin, K., Kwon, S., Nederlof, M. A., Gray, J. W., & Gibbs, S. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-03135-9 · Cited by 41
Inhalant Cannabidiol Inhibits Glioblastoma Progression Through Regulation of Tumor Microenvironment
Khodadadi, H., Salles, É. L., Alptekin, A., Mehrabian, D., Rutkowski, M. J., Arbab, A. S., Yeudall, W. A., Yu, J. C.-K., Morgan, J. C., Hess, D. C., et al. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0098 · Cited by 45
Aghayev, T., Mazitova, A., Fang, J. R., Peshkova, I. O., Rausch, M. P., Hung, M., White, K., Masia, R., Titerina, E. K., Fatkhullina, A. R., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1628 · Cited by 39
Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer
Ratajczak‐Wielgomas, K., Kmiecik, A. M., Grzegrzółka, J., Piotrowska, A., Gomułkiewicz, A., Partyńska, A., Pawełczyk, K., Nowińska, K., Podhorska‐Okołów, M., & Dzięgiel, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197025 · Cited by 37
Role of Autophagy in the Microenvironment of Oral Squamous Cell Carcinoma
Peña‐Oyarzún, D., Reyes, M., Hernández‐Cáceres, M. P., Kretschmar, C., Morselli, E., Ramírez‐Sarmiento, C. A., Lavandero, S., Torres, V. A., & Criollo, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.602661 · Cited by 38
Shueng, P., Yu, L.-Y., Chiu, H., Chang, H.-C., Chiu, Y., Kuo, T.-Y., Yen, Y.-W., & Lo, C.-L. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121012 · Cited by 37
A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy
Pastuch-Gawołek, G., Szreder, J., Domińska, M., Pielok, M., Cichy, P., & Grymel, M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030913 · Cited by 39
Serrano‐Martínez, A., Victoria‐Montesinos, D., García‐Muñoz, A. M., Hernández-Sánchez, P., Lucas-Abellán, C., & González-Louzao, R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071824 · Cited by 39
Roma‐Rodrigues, C., Pombo, I., Fernandes, A. R., & Baptista, P. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218017 · Cited by 43
Self-citationYang, B., Su, Z., Chen, G., Zeng, Z., Tan, J., Wu, G., Zhu, S., & Lin, L. (2021) · Oncology Letters · doi:10.3892/ol.2021.12441 · Cited by 36
Focal adhesion kinase inhibitors, a heavy punch to cancer
Wu, Y., Li, N., Ye, C., Jiang, X., Luo, H., Zhang, B., Zhang, Y., & Zhang, Q. (2021) · Discover Oncology · doi:10.1007/s12672-021-00449-y · Cited by 40
Ahmad, J., Rizwanullah, M., Suthar, T., Albarqi, H. A., Ahmad, M. Z., Vuddanda, P. R., Khan, M. A., & Jain, K. (2022) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2022040686 · Cited by 38
Chasara, R. S., Ajayi, T. O., Leshilo, D. M., Poka, M., & Witika, B. A. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19896 · Cited by 39
Nanosystems for chemodynamic based combination therapy: Strategies and recent advances
Li, M., Zhang, W., Xu, X., Liu, G., Dong, M., Sun, K., & Zhang, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1065438 · Cited by 38
Engineered bacteria for augmented in situ tumor vaccination
Shen, X., Zhu, C., Liu, X., Zheng, H., Wu, Q., Xie, J., Huang, H., Liao, Z., Shi, J., Nan, K., et al. (2023) · Biomaterials Science · doi:10.1039/d2bm01593e · Cited by 38
Woods, L. T., Jasmer, K. J., Forti, K. M., Shanbhag, V., Camden, J. M., Erb, L., Petris, M. J., & Weisman, G. A. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2020.104808 · Cited by 37
3D bioprinting for in vitro models of oral cancer: Toward development and validation
Almela, T., Tayebi, L., & Moharamzadeh, K. (2021) · Bioprinting · doi:10.1016/j.bprint.2021.e00132 · Cited by 38
Regulation of in vivo delivery of nanomedicines by herbal medicines
Guan, J., Chen, W., Yang, M., Wu, E., Qian, J., & Zhan, C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.015 · Cited by 37
Pericytes cross-talks within the tumor microenvironment
Picoli, C. C., Gonçalves, B. Ô. P., Santos, G. S. P., Rocha, B. G. S., Costa, A. C., Resende, R. R., & Birbrair, A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188608 · Cited by 36
Extracellular vesicles in pharmacology: Novel approaches in diagnostics and therapy
Quadri, Z., Elsherbini, A. M., & Bieberich, E. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105980 · Cited by 40
In Vivo Imaging of Pro- and Antitumoral Cellular Components of the Tumor Microenvironment
Helfen, A., Roth, J., Ng, T., & Eisenblätter, M. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.198952 · Cited by 35
Kasprzak, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043665 · Cited by 44
Secretome Analysis: Reading Cellular Sign Language to Understand Intercellular Communication
Wu, W., & Krijgsveld, J. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100692 · Cited by 43
Impact of Extracellular Matrix Components to Renal Cell Carcinoma Behavior
Majo, S., Courtois, S., Souleyreau, W., Bikfalvi, A., & Auguste, P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00625 · Cited by 39
Kim, S.-K., Jang, S. D., Kim, H., Chung, S. H., Park, J. K., & Kuh, H. (2020) · Cancers · doi:10.3390/cancers12051305 · Cited by 39
Metadata
- Authors
- Roma-Rodrigues, C., Mendes, R., Baptista, P. V., & Fernandes, A. R.
- Affiliations
- UCIBIO, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa. Campus de Caparica, 2829-516 Caparica, Portugal
- Universidade Nova de Lisboa (PT)
- Corresponding author
- Baptista, Pedro V.
- Fernandes, Alexandra R.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-02-15
- Volume
- 20
- Issue
- 4
- Pages
- 840
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6413095
- OpenAlex
- W2913062750
- Cited by
- 1,187
- References
- 212
- Citations by year
- 2026: 76 · 2025: 134 · 2024: 156 · 2023: 229 · 2022: 186 · 2021: 216 · 2020: 139 · 2019: 47
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- Ministério da Ciência, Tecnologia e Ensino Superior (UID/Multi/04378/2019, SFRH/BPD/124612/2016)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- tumor microenvironment, cancer therapy, Warburg effect, tumor hypoxia, oxidative stress, extracellular matrix, tumor stromal cells, tumor-associated macrophages, angiogenesis, metastasis, exosomes, nanomedicine, combination therapy, tumor models, tumor-on-a-chip, tumor spheroids
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasms, Neovascularization, Pathologic, Nanomedicine, Molecular Targeted Therapy, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.